Tirzepatide is primarily indicated for the treatment of T2D and is expected to receive its decision from the FDA in Q2 2022
The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare
ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment
Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%
The facility is among 12 centres established worldwide, and the first in Asia
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
Subscribe To Our Newsletter & Stay Updated
